243 related articles for article (PubMed ID: 29197357)
1. Assessing the outcomes of HIV-infected persons receiving treatment for Kaposi sarcoma in Conakry-Guinea.
Bekolo CE; Soumah MM; Tiemtore OW; Diallo A; Yuma JD; Di Stefano L; Metcalf C; Cisse M
BMC Cancer; 2017 Dec; 17(1):806. PubMed ID: 29197357
[TBL] [Abstract][Full Text] [Related]
2. Recommendations for treating life-threatening Kaposi sarcoma during pregnancy in HIV-positive women in low income countries.
Bacha JM; El-Mallawany NK; Slone JS; Wilkinson JP; Mehta PS; Campbell LR
Int J STD AIDS; 2020 Jul; 31(8):724-734. PubMed ID: 32493141
[TBL] [Abstract][Full Text] [Related]
3. Chemotherapy for AIDS-related and endemic African Kaposi's sarcoma in southern Africa.
Stein ME; Lachter J; Spencer D; Bezwoda WR
Int J Dermatol; 1995 Oct; 34(10):729-32. PubMed ID: 8537166
[TBL] [Abstract][Full Text] [Related]
4. Clinical Factors Associated with Long-Term Complete Remission versus Poor Response to Chemotherapy in HIV-Infected Children and Adolescents with Kaposi Sarcoma Receiving Bleomycin and Vincristine: A Retrospective Observational Study.
El-Mallawany NK; Kamiyango W; Slone JS; Villiera J; Kovarik CL; Cox CM; Dittmer DP; Ahmed S; Schutze GE; Scheurer ME; Kazembe PN; Mehta PS
PLoS One; 2016; 11(4):e0153335. PubMed ID: 27082863
[TBL] [Abstract][Full Text] [Related]
5. Excellent clinical outcomes and retention in care for adults with HIV-associated Kaposi sarcoma treated with systemic chemotherapy and integrated antiretroviral therapy in rural Malawi.
Herce ME; Kalanga N; Wroe EB; Keck JW; Chingoli F; Tengatenga L; Gopal S; Phiri A; Mailosi B; Bazile J; Beste JA; Elmore SN; Crocker JT; Rigodon J
J Int AIDS Soc; 2015; 18(1):19929. PubMed ID: 26028156
[TBL] [Abstract][Full Text] [Related]
6. Triple therapy of vincristine, bleomycin and etoposide for children with Kaposi sarcoma: Results of a study in Malawian children.
Macken M; Dale H; Moyo D; Chakmata E; Depani S; Israels T; Niyrenda D; Bailey S; Chagaluka G; Molyneux EM
Pediatr Blood Cancer; 2018 Feb; 65(2):. PubMed ID: 28988435
[TBL] [Abstract][Full Text] [Related]
7. Treatment outcomes of AIDS-associated Kaposi's sarcoma under a routine antiretroviral therapy program in Lilongwe, Malawi: bleomycin/vincristine compared to vincristine monotherapy.
Mwafongo AA; Rosenberg NE; Ng'ambi W; Werner AB; Garneau WM; Gumulira J; Phiri S; Hosseinipour MC
PLoS One; 2014; 9(3):e91020. PubMed ID: 24632813
[TBL] [Abstract][Full Text] [Related]
8. Effect of protease inhibitor-based highly active antiretroviral therapy on survival in HIV-associated advanced Kaposi's sarcoma patients treated with chemotherapy.
Leitch H; Trudeau M; Routy JP
HIV Clin Trials; 2003; 4(2):107-14. PubMed ID: 12671778
[TBL] [Abstract][Full Text] [Related]
9. Treatment of Kaposi sarcoma in children with HIV-1 infection.
Anglemyer A; Agrawal AK; Rutherford GW
Cochrane Database Syst Rev; 2014 Jan; (1):CD009826. PubMed ID: 24464843
[TBL] [Abstract][Full Text] [Related]
10. Etoposide, vincristine, doxorubicin and dexamethasone (EVAD) combination chemotherapy as second-line treatment for advanced AIDS-related Kaposi's sarcoma.
Zhong DT; Shi CM; Chen Q; Huang JZ; Liang JG; Lin D
J Cancer Res Clin Oncol; 2012 Mar; 138(3):425-30. PubMed ID: 22160130
[TBL] [Abstract][Full Text] [Related]
11. [Kaposi sarcoma in HIV patients: Response to antiretroviral treatment and chemotherapy].
Lasso M; Pérez J; Noriega L; Malebrán A; Espinoza S
Rev Med Chil; 2003 May; 131(5):483-90. PubMed ID: 12879808
[TBL] [Abstract][Full Text] [Related]
12. Treatment of advanced AIDS-associated Kaposi sarcoma in resource-limited settings: a three-arm, open-label, randomised, non-inferiority trial.
Krown SE; Moser CB; MacPhail P; Matining RM; Godfrey C; Caruso SR; Hosseinipour MC; Samaneka W; Nyirenda M; Busakhala NW; Okuku FM; Kosgei J; Hoagland B; Mwelase N; Oliver VO; Burger H; Mngqibisa R; Nokta M; Campbell TB; Borok MZ;
Lancet; 2020 Apr; 395(10231):1195-1207. PubMed ID: 32145827
[TBL] [Abstract][Full Text] [Related]
13. Treatment and outcome of AIDS-related Kaposi sarcoma in South Africa, Malawi and Zambia: an international comparison.
Rohner E; Kasaro M; Msadabwe-Chikuni SC; Stinson K; Mohamed Z; Tweya H; Egger M; Bohlius J
Pan Afr Med J; 2017; 28():261. PubMed ID: 29881504
[TBL] [Abstract][Full Text] [Related]
14. As-Needed Vs Immediate Etoposide Chemotherapy in Combination With Antiretroviral Therapy for Mild-to-Moderate AIDS-Associated Kaposi Sarcoma in Resource-Limited Settings: A5264/AMC-067 Randomized Clinical Trial.
Hosseinipour MC; Kang M; Krown SE; Bukuru A; Umbleja T; Martin JN; Orem J; Godfrey C; Hoagland B; Mwelase N; Langat D; Nyirenda M; MacRae J; Borok M; Samaneka W; Moses A; Mngqbisa R; Busakhala N; Martínez-Maza O; Ambinder R; Dittmer DP; Nokta M; Campbell TB;
Clin Infect Dis; 2018 Jul; 67(2):251-260. PubMed ID: 29365083
[TBL] [Abstract][Full Text] [Related]
15. Long-term efficacy on Kaposi's sarcoma of highly active antiretroviral therapy in a cohort of HIV-positive patients. CISIH 92. Centre d'information et de soins de l'immunodéficience humaine.
Dupont C; Vasseur E; Beauchet A; Aegerter P; Berthé H; de Truchis P; Zucman D; Rouveix E; Saiag P
AIDS; 2000 May; 14(8):987-93. PubMed ID: 10853980
[TBL] [Abstract][Full Text] [Related]
16. A randomized controlled trial of highly active antiretroviral therapy versus highly active antiretroviral therapy and chemotherapy in therapy-naive patients with HIV-associated Kaposi sarcoma in South Africa.
Mosam A; Shaik F; Uldrick TS; Esterhuizen T; Friedland GH; Scadden DT; Aboobaker J; Coovadia HM
J Acquir Immune Defic Syndr; 2012 Jun; 60(2):150-7. PubMed ID: 22395672
[TBL] [Abstract][Full Text] [Related]
17. Real-world use of chemotherapy for Kaposi's sarcoma in a large community-based HIV primary care system in Kenya.
Freeman EE; Busakhala N; Regan S; Asirwa FC; Wenger M; Seth D; Moon KC; Semeere A; Maurer T; Wools-Kaloustian K; Bassett I; Martin J
BMC Cancer; 2020 Jan; 20(1):71. PubMed ID: 31996161
[TBL] [Abstract][Full Text] [Related]
18. Clinical characteristics, predictors of immune reconstitution inflammatory syndrome and long-term prognosis in patients with Kaposi sarcoma.
Volkow P; Cesarman-Maus G; Garciadiego-Fossas P; Rojas-Marin E; Cornejo-Juárez P
AIDS Res Ther; 2017 May; 14(1):30. PubMed ID: 28558783
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic Outcomes in AIDS-Associated Kaposi's Sarcoma Patients on Antiretroviral Therapy Treated with Chemotherapy at Two Tertiary Hospitals in Lusaka, Zambia.
Mtonga W; Mujajati A; Munkombwe D; Kalungia A; Muungo LT; West J; Wood C; Ngalamika O
Curr HIV Res; 2018; 16(3):231-236. PubMed ID: 29992888
[TBL] [Abstract][Full Text] [Related]
20. Randomized Phase IIA Trial of Gemcitabine Compared With Bleomycin Plus Vincristine for Treatment of Kaposi's Sarcoma in Patients on Combination Antiretroviral Therapy in Western Kenya.
Busakhala NW; Waako PJ; Strother MR; Keter AK; Kigen GK; Asirwa FC; Loehrer PJ
J Glob Oncol; 2018 Sep; 4():1-9. PubMed ID: 30241150
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]